Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3416086 | Microbes and Infection | 2006 | 7 Pages |
Abstract
Interleukin (IL)-12/IL-23 signal transduction-deficient individuals with genetic defects in IL12RB1 or IL12B often suffer from unusual mycobacterial and Salmonella infections. Here we discuss recent questions that have arisen from clinical observations that cast doubt on the necessity of IL-12/IL-23 signaling in controlling infections with intracellular bacteria. Alternative IL-12/IL-23-dependent, interferon-γ-independent pathways of immunity to intracellular bacteria are also discussed.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Esther van de Vosse, Tom H.M. Ottenhoff,